The BCMA assay was applied to patient samples collected from patients with MGUS (monoclonal gammopathy of undetermined significance), SMM (smoldering MM), NDMM (newly diagnosed MM), RRMM (relapsed/refractory MM), and LPL (lymphoplasmacytic leukemia). This evidence concerns the gene LPL and Miyoshi myopathy.